Correlation of ELN-Risk and Gene Mutations with Quizartinib Efficacy in Patients with FLT3-ITD-Negative Newly Diagnosed Acute Myeloid Leukemia in the Phase 2 Quiwi Pethema Trial
0
Authors
David Martínez‐Cuadrón
David Martínez‐Cuadrón•Rebeca Rodríguez‐Veiga•Pau Montesinos